Shi Zhe, Rifa'i Muhaimin, Lee Young Ho, Shiku Hiroshi, Isobe Ken-Ichi, Suzuki Haruhiko
Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Immunology. 2008 May;124(1):121-8. doi: 10.1111/j.1365-2567.2007.02747.x. Epub 2008 Jan 16.
CD8+CD122+ regulatory T cells are a newly identified, naturally occurring type of regulatory T cell that produce interleukin-10 (IL-10) and effectively suppress interferon-gamma (IFN-gamma) production from both CD8+ and CD4+ target cells. Molecular mechanisms responsible for the recognition of target cells by CD8+CD122+ regulatory T cells were investigated in this study by using an in vitro culture system that reconstitutes the regulatory action of these cells. CD8+CD122( regulatory T cells did not produce IL-10 and did not suppress the IFN-gamma production of allogeneic target T cells when they were stimulated by immobilized anti-CD3 antibody alone, but they clearly produced IL-10 and suppressed the IFN-gamma production of target cells when stimulated by anti-CD3 plus anti-CD28-coated beads. IFN-gamma production by major histocompatibility complex-class I-deficient T cells was also suppressed by CD8+CD122+ regulatory T cells stimulated with anti-CD3 plus anti-CD28 antibody but was not suppressed by cells stimulated by anti-CD3 alone. Experiments examining the blockade of cell surface molecules expressed on either the regulatory cells or the target cells by adding specific neutralizing antibodies in the culture indicated that CD80, CD86, and CD28 molecules were involved in the regulatory action, but cytotoxic T lymphocyte antigen-4, inducible costimulatory molecule (ICOS) and programmed death-1 (PD-1) molecules were not. Finally, CD8+CD122+ cells isolated from CD28-knockout (CD28-/-) mice showed no regulatory activity. These results indicate that CD8+CD122(+) regulatory T cells recognize target T cells via the interaction of CD80/CD86-CD28 molecules to become active regulatory cells that produce suppressive factors such as IL-10.
CD8+CD122+调节性T细胞是一种新发现的天然存在的调节性T细胞类型,它可产生白细胞介素-10(IL-10),并有效抑制CD8+和CD4+靶细胞产生干扰素-γ(IFN-γ)。本研究通过使用一种体外培养系统来重建这些细胞的调节作用,从而研究了CD8+CD122+调节性T细胞识别靶细胞的分子机制。当单独用固定化抗CD3抗体刺激时,CD8+CD122(调节性T细胞不产生IL-10,也不抑制同种异体靶T细胞的IFN-γ产生,但当用抗CD3加抗CD28包被的珠子刺激时,它们明显产生IL-10并抑制靶细胞的IFN-γ产生。主要组织相容性复合体I类缺陷T细胞产生的IFN-γ也受到抗CD3加抗CD28抗体刺激的CD8+CD122+调节性T细胞的抑制,但不受单独抗CD3刺激的细胞的抑制。通过在培养物中添加特异性中和抗体来检测调节细胞或靶细胞上表达的细胞表面分子的阻断实验表明,CD80、CD86和CD28分子参与了调节作用,但细胞毒性T淋巴细胞抗原-4、诱导性共刺激分子(ICOS)和程序性死亡-1(PD-1)分子未参与。最后,从CD28基因敲除(CD28-/-)小鼠中分离出的CD8+CD122+细胞没有调节活性。这些结果表明,CD8+CD122(+)调节性T细胞通过CD80/CD86-CD28分子的相互作用识别靶T细胞,从而成为产生IL-10等抑制因子的活性调节细胞。